Effects of Croton cajucara extract on serum lipids of rats fed a high fat diet

Phytotherapy Research

Volumn 10, Issue 8, 1996, Pages 697-699

  Farias, R A F ^a   Neto, M F O ^a   Viana, G S B ^a   Rao, V S N ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

atherogenic index; Croton cajucara Benth.; hydroalcoholic extract; hypolipaemic activity

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; CROTON CAJUCARA EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; LIPID BLOOD LEVEL; LIPID DIET; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLANT LEAF; RAT;

ANIMALIA; CROTON; CROTON CAJUCARA; EUPHORBIACEAE;

EID: 0030483913     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1573(199612)10:8<697::AID-PTR925>3.0.CO;2-I     Document Type: Article

References (19)

1. Alberts, A. W., Chen, J., Kuron, G. et al. (1980). Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase and a cholesterol lowering agent. Proc. Natl Acad. Sci. USA 77, 3957-3961.
2. Arichi, H., Kimura, Y., Okuda, H., Baba, K., Kozawa, M., and Arichi, S. (1982). Effects of stilbene components of the roots of Polygonum cuspidatom Sieb, et Zucc. on lipid metabolism. Chem. Pharm. Bull. 30, 1766-1770.
3. Bagdads, J. D., Lane, J. T., Stone, N., Ritter, M. C., and Subbaiah, R V. (1990). Persistent abnormalities in lipoprotein composition and cholesteryl ester transfer following lovastatin treatment. J. Lipid Res. 31, 1263-1269.
4. Beutler, J. A., Alvarado, A. B., McCloud, T. G., and Cragg, G. M. (1989). Distribution of phorbol ester bioactivity in the Euphorbiaceae. Phytother. Res. 3, 188-192.
5. Choi, J. S., Yokozawa, T., and Oura, H. (1991). Antihyperlipidemic effect of flavonoids from Prunus davidiana. J. Nat. Prod. 54, 218-224.
6. Creager, M. A., Cooke, J. R, Mendelsohn, M. D. et al. (1990). Impaired vasodilatation of forearm resistance vessels in hypercholesterolemic humans. J. Clin. Invest. 86, 228-234.
7. Di Stasi, L C., Santos, E. M. G., Santos, C. M., and Hiruma, A. C. (1989). Plantas Medicinais na Amazônia pp. 127-128, Editora Fundaçǎo Para o Desenvolvimento da Universidade Estadual Paulista; São Paulo.
8. Friedwald, W. T., Levy, R. I., and Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502.
9. Heider, J. G. (1986). In, Pharmacological Control of Hyperlipidaemia, ed. by R. Fears, pp. 423-438, J. R. Prous. Barcelona, Spain.
10. Ichihara, Y., Takeya, K., Hitotsuyanagi, Y. et al. (1992). Cajucarinolide and Isocajucarinolide from Croton cajucara. Planta Med. 58, 549-551.
11. Margot, T., Malmendier, C. L., Ouguerram, K., Lontie, J. F., and Lutton, C. (1991). In vivo effect of Simvastatin on lipoprotein cholestery) ester metabolism in normocholesterolemic volunteers. Clin. Chim. Acta. 196, 5968.
12. Martins, J. E. C. (1989). Plantas Medicinais de uso na Amazônia. p. 92, Centro de Estudos Juridicos do Para, Belém.
13. 2 cholesterolemia with abnormal cholesteryl ester transfer. Am. J. Cardiol. 62, 66B-72B.
14. 50 and its error by means of logarithimic probit graph paper. Proc. Soc. Exp. Biol. Med. 57, 261-264.
15. Ohata, I., Sakamoto, N., Nagano, K., and Maeno, H. (1984). Low density lipoprotein-lowering and high density lipoprotein elevating effects of nicardipine in rats. Biochem. Pharm. 33, 2199-2205.
16. Schmidt, S. B., Wasserman, A. G., Muesing, R. A., Schlesselman, S. A., Larosa, J. C., and Ross, A. M. (1985). Lipoprotein and apolipoprotein levels in angiographically defined coronary. Am. J. Cardiol. 55, 1459-1462.
17. Schmidt, R. J. (1986). Biosystematic and chemosystematic aspects of the Euphorbiaceae and Thymelaceaceae. In, Naturally Occurring Phorbol Esters, ed. by F. J. Evans, pp. 87-106, CRC Press, Boca Raton, FL, USA.
18. Sliskovic, D. R., and White, A. D. (1991). Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents, Ti PS 12, 194-199.
19. Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., and Witztum, J. L. (1989). Beyond cholesterol. Modification of low-density lipoprotein that increase its atherogenicity. New Engl. J. Med. 320, 915-924.